dbio NEWS
& MEDIA
  • Facebook - Black Circle
  • Twitter - Black Circle
  • YouTube - Black Circle

follow US

Jacob Glanville on The Claman Countdown

June 29, 2020

1/5
Please reload

FOLLOW US

NEWS

RSS Feed
 

June 29, 2020

Jake returned to the Claman Countdown on Fox Business to discuss the status of the pandemic, how new cases of coronavirus will continue to spike until we have a viable medicine or vaccine that can be made available to the entire world, and how our treatment is working...

June 27, 2020

A potential treatment for covid-19 is a step closer to reality with a promising study involving hamsters showing a 97% reduction of coronavirus in lungs within 48 hours of treatment. Dr Jacob Glanville head of US company Distributed Bio has been working on the developm...

June 23, 2020

Jacob Glanville is fascinated by the intersection of technology and medicine. Fueled by his experiences growing up in war-torn Guatemala, he wondered how he could use technology to create a post-pathogen world. Now, as CEO of Distributed Bio, he’s achieving that vision...

June 23, 2020

In this episode of "Let's Give a Damn," with Nick LaParra, Sarah and Nick talk about her work on the universal flu vaccine and a coronavirus treatment, what it’s like to work on a cure that could change the world, her deep love for Guatemala, and more. Listen to the ep...

Please reload

PRESS

 

Distributed Bio in the news

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

BUSINESS WIRE | Oct 25, 2018

Distributed Bio's efforts to 

BUSINESS WIRE | Oct 25, 2018

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

BUSINESS WIRE | Oct 25, 2018

Distributed Bio Announces SuperHuman Platform Transfer to Kadmon

BUSINESS WIRE | Feb. 28, 2018

Pfizer, Boehringer sign JLABS resident Distributed Bio’s antibody discovery platform

FIERECE BIOTECH | Jan. 11, 2018

Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.

BUSINESS WIRE | Jan. 5 2018

Distributed Bio, Inc. and Pandion Therapeutics, Inc. Announce Multi-Target Collaboration

BUSINESS WIRE | Dec. 12, 2017

Distributed Bio and Boehringer Ingelheim Announce SuperHuman Platform Transfer

BUSINESS WIRE | Dec. 11, 2017

VIDEOS

All videos are free to view & download

 

PUBLICATIONS

 

OUR CENTIVAX TECHNOLOGY 

HAS BEEN PATENTED 

PRESENTATIONS

All presentations are free to view & download

 

SUPERHUMAN 2.0

CARTERRA

PROTEIN ENGINEERING

SUMMIT

IBC TALK 2017

PEGS 2012

THE BETTER BIOLOGIC

PEGS 2013

REPERTOIRE ANALYSIS

& BIOLOGICS OPTIMIZATIONS

NOVEL SEQUENCING TECHNIQUES & COMPUTATIONAL DISCOVERY

CHARACTERIZING HERITABLE VARIATION IN THE ANTIBODY REPERTOIRE

(415) 489-0246

201 Gateway Blvd, Floor 1

 South San Francisco, CA 94080, USA